Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
NCT00735397
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1218
Enrollment
INDUSTRY
Sponsor class
Conditions
Epilepsy
Interventions
DRUG:
perampanel
Sponsor
Eisai Inc.